Print4Kids: 3D-Printed Prednisolone Tablets in Pediatrics – Taste Masking and Improved Acceptance

Print4Kids: 3D-Printed Prednisolone Tablets in Pediatrics – Taste Masking and Improved Acceptance - Print4Kids

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00040396

Enrollment

Registered

2026-05-21

Start date

2026-05-22

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Improvement of Corticosteroid therapy for immunological/hematological disorders (ALL)/ juvenile idiopathic arthritis (JIA)

Interventions

Group 1: Observational study: age-appropriate survey following the administration of 3D-printed tablets (two versions in different orders) compared to standard medication

Eligibility

Sex/Gender

All

Age

1 Years to 18 Years

Inclusion criteria

Inclusion criteria: Patients with a prescription for oral prednisolone (2 mg or more)

Exclusion criteria

Exclusion criteria: Known intolerance to one or more of the ingredients in the 3D-printed tablets; Age < 1 year (Ingredients in CuraBlend base: Purified water, xylitol, gelatin, cocoa butter, glycerol 85%, maltodextrin, silicon dioxide, citric acid monohydrate, sodium citrate, vanilla flavor, potassium sorbate, raspberry flavor, sucralose)

Design outcomes

Primary

Measure	Time frame
Achieving the target sample size (60 patients) Assessing the acceptance and taste perception of 3D-printed prednisolone/prednisolone disodium dihydrogen phosphate tablets among children and adolescents (using a questionnaire)	—

Countries

Germany

Contacts

Public ContactJana Giesel-Gerstmeier

Helios Klinikum Erfurt

Jana.Giesel-Gerstmeier@helios-gesundheit.de+4915201885294

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 10, 2026